Nuclear imaging methods for non-invasive drug monitoring

This publication has 33 references indexed in Scilit:

• Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters
  Synapse, 1998
• Development of a positron emission tomography radiopharmaceutical for imaging thymidine kinase gene expression: Synthesis and in vitro evaluation of 9-{3-[18F] Fluoro-1-hydroxy-2-propoxymethyl guanine
  Bioorganic & Medicinal Chemistry Letters, 1997
• Imaging of dopamine transporters in humans with technetium-99m TRODAT 1
  European Journal of Nuclear Medicine and Molecular Imaging, 1996
• Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography
  European Journal of Nuclear Medicine and Molecular Imaging, 1994
• Striatal D₂ receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with ¹¹C‐raclopride and positron emission tomography
  Annals of Neurology, 1992
• PET demonstrates different behaviour of striatal dopamine D‐1 and D‐2 receptors in early Parkinson's disease
  Journal of Neuroscience Research, 1990
• A Method for the In Vivo Investigation of the Serotonergic 5‐HT₂ Receptors in the Human Cerebral Cortex Using Positron Emission Tomography and ¹⁸F‐Labeled Setoperone
  Journal of Neurochemistry, 1990
• Factors affecting sensitivity and specificity of a diagnostic test: the exercise thallium scintigram
  The American Journal of Medicine, 1988
• Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using¹¹C-N-methyl-spiperone
  Acta Neurologica Scandinavica, 1987
• Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis.
  Circulation, 1984